7 December 2021, Dajiaweikang Pharmaceutical Industry Co., Ltd. listed on the ChiNext market at Shenzhen Stock Exchange (stock code: 301126). Acting for the issuer lawyer, Llinks advised the full legal services.
As a leading regional pharmaceutical distribution company, Dajiaweikang is mainly engaged in the distribution and retail business of pharmaceuticals, biological products, medical equipment and other products. Relying on the integration of wholesale and retail, and taking advantage of the supply chain, the company has developed new retail models for specialized pharmacies such as DTP pharmacies, chronic disease management pharmacies, new specialty pharmacies, and "dual channel" pharmacies. With the advancement of the national policy of separation of medicines and prescription outflow, the society's demand for professional pharmaceutical services continues to escalate. As a platform for connecting pharmaceutical companies, hospitals and patients, the rise of professional pharmacies such as Dajiaweikang is at the right time. In addition, Dajiaweikang also set up a special hospital for reproductive and genetics, and deployed to the hospital terminal to further improve the structure of the big health industry chain.
